Welcome to our dedicated page for Nevro news (Ticker: NVRO), a resource for investors and traders seeking the latest updates and insights on Nevro stock.
Nevro Corp (NYSE: NVRO), a pioneer in neuromodulation therapies for chronic pain management, provides this centralized hub for investors and healthcare professionals to access its latest developments. Track official press releases, clinical milestones, and business updates from the creator of the Senza spinal cord stimulation system.
This resource delivers timely updates on NVRO's FDA clearances, international expansions, and evidence-based innovations like its AI-enhanced HFX platform. Users will find disclosures covering product launches, financial results, and strategic partnerships that shape chronic pain treatment globally.
Key updates include advancements in 10 kHz therapy clinical applications, regulatory approvals across markets, and operational developments impacting patient access. Bookmark this page to stay informed about Nevro's progress in redefining neuromodulation standards through engineering and clinical excellence.
Nevro Corp. (NYSE: NVRO) will participate in the BofA Securities 2024 Healthcare Conference on May 14, 2024, presenting comprehensive pain treatment solutions. A webcast of the event will be available on the company's website.
Nevro Corp. reported its first-quarter 2024 financial results along with additional restructuring steps to boost profitability. The company raised its adjusted EBITDA guidance, reaffirmed revenue guidance for 2024, and promoted Christofer Christoforou to COO. Revenue grew to $101.9 million, with a net loss from operations of $35.8 million and adjusted EBITDA loss of $9.6 million. The company's improved gross margin, operating expenses, and cash position were highlighted. Full-year revenue guidance stands at $435 million to $445 million, with adjusted EBITDA guidance revised to a range of negative $5 million to positive $2 million for 2024.
FAQ
What is the current stock price of Nevro (NVRO)?
What is the market cap of Nevro (NVRO)?
